Safety of baricitinib in patients with alopecia areata

Br J Dermatol. 2023 Feb 10;188(2):163. doi: 10.1093/bjd/ljac080.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alopecia Areata* / drug therapy
  • Azetidines* / adverse effects
  • Humans
  • Sulfonamides / adverse effects

Substances

  • baricitinib
  • Azetidines
  • Sulfonamides

Supplementary concepts

  • Diffuse alopecia